Discussion about this post

User's avatar
Ben Wheeler's avatar

Quick note -- your first bullet, summarizing Ashar et al. 2021, has the numbers slightly wrong, from my read of that paper. The decline in the PRT treatment group was from 4.1/10 to 1.2/10 (vs. 2.8/10 for placebo) -- still a big deal, but a decline of about 2.9/10, not a decline of 4.5/10 as you state. And while the improvement did persist, after 1 year there was some regression; to 1.5/10 for treatment, while placebo was still 2.8.

Expand full comment
1 more comment...

No posts